Answer
Yes, hair loss (alopecia) is a recognised adverse effect of tisotumab vedotin, reported in 31% of patients in clinical studies.
Sources for this answer
- TivdakGenmab A/S · emc · SmPC §4.8 Undesirable effects · Version 1Document updated
Sources checked